Sanofi ADR earnings, Revenue beat in Q3

  • Investing.com
Sanofi ADR earnings, Revenue beat in Q3
Credit: © Reuters.

Investing.com - Sanofi (PA: SASY ) ADR reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.

Sanofi ADR announced earnings per share of €1.26 on revenue of €12.1B. Analysts polled by Investing.com anticipated EPS of €1.15 on revenue of €11.99B.

Sanofi ADR shares are up 41% from the beginning of the year and are trading at €49.57 , down-from-52-week-high.They are outperforming the AEX which is up 30.35% year to date.

Sanofi ADR follows other major Healthcare sector earnings this month

Sanofi ADR's report follows an earnings beat by J&J on Tuesday, October 19, 2021, who reported EPS of €2.6 on revenue of €23.34B, compared to forecasts EPS of €2.35 on revenue of €23.64B.

Thermo Fisher Scientific had beat expectations on Wednesday with third quarter EPS of €5.76 on revenue of €9.33B, compared to forecast for EPS of €4.68 on revenue of €8.33B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles